Since CLVS wants to do it alone for a while, they need money. So, financing is just a matter of time.
Furthermore, for money changers, CLVS is a "dead" stock since no news for another 3 months. Take into account that there is very little clinical data available from CLVS CO-1686 or AZN AZD-9291 in EGFR T790M+ NSCLC, consequently, there are many risks and plenty speculations.
PS Just look how much money money-changers made today in GILD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.